Search

Your search keyword '"Hu, Zhiyuan"' showing total 1,762 results

Search Constraints

Start Over You searched for: Author "Hu, Zhiyuan" Remove constraint Author: "Hu, Zhiyuan"
1,762 results on '"Hu, Zhiyuan"'

Search Results

206. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors

208. Comparative Study of Soft In-Plane and Stiff In-Plane Tiltrotor Blade Aerodynamics in Conversion Flight, Using CFD-CSD Coupling Approach.

209. Analysis of the Aeroacoustic Characteristics of a Rigid Coaxial Rotor in Forward Flight Based on the CFD/VVPM Hybrid Method.

211. Water–Salt Migration Patterns among Cropland–Wasteland–Fishponds in the River-Loop Irrigation Area.

212. Numerical Study on Aerodynamic and Noise Responses of Rotor with Ramp Increase in Collective Pitch Based on Time-Accurate Free-Wake Method.

215. A Novel Discrimination Structure for Assessing Text Semantic Similarity

222. Supplementary File S1 from Enhanced Immunogenicity of Mitochondrial-Localized Proteins in Cancer Cells

223. Data from Enhanced Immunogenicity of Mitochondrial-Localized Proteins in Cancer Cells

224. Supplementary Figures and Tables from Enhanced Immunogenicity of Mitochondrial-Localized Proteins in Cancer Cells

227. Supplementary Materials and Methods. Immunohistochemical staining and automated analysis methods from Performance of Three-Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER Consortium

228. Supplementary Data and Figures from Anti-PD-1 Antibody SHR-1210 Combined with Apatinib for Advanced Hepatocellular Carcinoma, Gastric, or Esophagogastric Junction Cancer: An Open-label, Dose Escalation and Expansion Study

229. Supplementary Table S2. Agreement between IHC-based and intrinsic subtype, using dichotomous biomarker IHC status from Performance of Three-Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER Consortium

230. Supplementary Data Files from Integrated Analysis of RNA and DNA from the Phase III Trial CALGB 40601 Identifies Predictors of Response to Trastuzumab-Based Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer

231. Supplementary eTables from Integrated Analysis of RNA and DNA from the Phase III Trial CALGB 40601 Identifies Predictors of Response to Trastuzumab-Based Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer

232. Supplementary Table S1. Core level agreement between automated and manual scoring of central tissue microarrays from Performance of Three-Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER Consortium

233. Supplementary Information from The Oxford Classic Links Epithelial-to-Mesenchymal Transition to Immunosuppression in Poor Prognosis Ovarian Cancers

234. Supplementary Table S3. Agreement between three biomarker IHC-based and intrinsic subtypes: impact of adding tumor grade to distinguish between luminal A and luminal B cases. from Performance of Three-Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER Consortium

235. Supplementary Figures from Integrated Analysis of RNA and DNA from the Phase III Trial CALGB 40601 Identifies Predictors of Response to Trastuzumab-Based Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer

Catalog

Books, media, physical & digital resources